Table 9 Relationship between treatments and health problems
From: Health profiles of 996 melanoma survivors: the M. D. Anderson experience
Treatment | Number of Patients* | Most Frequently Reported Health Effects | ||
|---|---|---|---|---|
Dacarbazine | 89 | Cardiovascular (12%), | lymphedema (8%), | arthritis (4%) |
Phenylalanine mustard | 65 | Cardiovascular (10%), | lymphedema (11%), | arthritis (5%) |
Radiation therapy | 63 | Radiation damage (8%), | cardiovascular (8%), | diabetes (5%) |
Interferon | 52 | Cardiovascular (6%), | skin problems (6%), | lymphedema (4%) |
Bacillus Calmette-Guerin | 42 | Cardiovascular (14%), | lymphedema (12%), | ulcer problems (5%) |
Cisplatin | 31 | Arthritis (6%), | cardiovascular (6%), | neuropathy (6%) |
Actinomycin-D | 22 | Cardiovascular (36%), | lymphedema (14%), | arthritis (9%) |
Vinblastine | 21 | Neuropathy (9%), | arthritis (5%), | |
Interleukin | 18 | Arthritis (6%), | cardiovascular (6%), | |
Vincristine | 17 | Cardiovascular (18%), | ||